Real-time enrollment status for this generalized anxiety disorder clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 1:59 AM UTC
| NCT Number | NCT07759128 |
| Recruiting Status | Recruiting |
| Condition | Generalized Anxiety Disorder |
| Phase | PHASE3 |
| Target Enrollment | 576 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Otsuka Pharmaceutical Development & Commercialization, Inc. |
| Last Updated on CT.gov | September 22, 2026 (3 weeks ago) |
As of October 16, 2026: Clinical trial NCT07759128 is currently recruiting participants. This phase3 study for generalized anxiety disorder is actively seeking new participants at 6 locations across the United States. The study is sponsored by Otsuka Pharmaceutical Development & Commercialization, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07759128 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07759128 was last updated 3 weeks ago (September 22, 2026). HelloStudys verifies this status automatically.